Rare diseases
Investigational molecules
Locations
22722 29th Drive Southeast Ste 100, 98021-4420, United States
Achieve Life Sciences Inc. concentrates its research efforts on developing innovative therapeutic solutions for individuals seeking to overcome tobacco dependence. The organisation's clinical programmes target the physiological and behavioural aspects of nicotine addiction, with particular emphasis on creating pharmacological interventions that address the complex mechanisms underlying smoking behaviour.
The company's research portfolio reflects a commitment to addressing substance use disorders through targeted pharmaceutical development, focusing on compounds that may alter the rewarding properties of nicotine consumption and facilitate sustained abstinence from tobacco products.
Achieve Life Sciences Inc. runs clinical trials in conditions such as Nicotine dependence, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
PortugalPortugalPortugalIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
